Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia

American Journal of Psychiatry

Volumn 168, Issue 2, 2011, Pages 202-209

  Swendsen, Joel ^a   Ben Zeev, Dror ^a   Granholm, Eric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ADULT; ALCOHOL CONSUMPTION; AMBULATORY MONITORING; ANXIETY DISORDER; ARTICLE; CANNABIS SMOKING; DELUSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; HALLUCINATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SELF MEDICATION; SUBSTANCE ABUSE;

ADULT; ALCOHOL DRINKING; COMORBIDITY; COMPUTERS, HANDHELD; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; MONITORING, AMBULATORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SELF MEDICATION; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 79952725303     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2010.10030463     Document Type: Article

References (40)

1. Buckley PF, Miller BJ, Lehrer DS, Castle DJ: Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009; 35:383-402
2. Gregg L, Barrowclough C, Haddock G: Reasons for increased substance use in psychosis. Clin Psychol Rev 2007; 27:494-510 (Pubitemid 46431229)
3. Mazzoncini R, Donoghue K, Hart J, Morgan C, Doody GA, Dazzan P, Jones PB, Morgan K, Murray RM, Fearon P: Illicit substance use and its correlates in first episode psychosis. Acta Psychiatr Scand 2010; 121:351-358
4. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370:319-328 (Pubitemid 47094993)
5. Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF: Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. Am J Psychiatry 2009; 166:1251-1257
6. Linszen DH, Dingemans PM, Lenior ME: Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51:273-279 (Pubitemid 24127299)
7. Mueser KT, Bellack AS, Blanchard JJ: Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol 1992; 60:845-856
8. Turkington A, Mulholland CC, Rushe TM, Anderson R, McCaul R, Barrett SL, Barr RS, Cooper SJ: Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry 2009; 195:242-248
9. Veen ND, Selten J-P, van der Tweel I, Feller WG, Hoek HW, Kahn RS: Cannabis use and age at onset of schizophrenia. Am J Psychiatry 2004; 161:501-506 (Pubitemid 38326105)
10. World Health Organization: The Global Burden of Disease: 2004 Update. Geneva, World Health Organization, 2008
11. Fazel S, Langstrom N, Hjern A, Grann M, Lichtenstein P: Schizophrenia, substance abuse, and violent crime. JAMA 2009; 301:2016-2023
12. Henquet C, Rosa A, Delespaul P, Papiol S, Fananás L, van Os J, Myin-Germeys I: COMT ValMet moderation of cannabisinduced psychosis: a momentary assessment study of "switching on" hallucinations in the flow of daily life. Acta Psychiatr Scand 2009; 119:156-160
13. Spano MS, Fadda P, Frau R, Fattore L, Fratta W: Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats. Eur Neuropsychopharmacol 2010; 20:25-36
14. Johnson EI, Barrault M, Nadeau L, Swendsen J: Feasibility and validity of computerized ambulatory monitoring in drug-dependent women. Drug Alcohol Depend 2009; 99: 322-326
15. Freedman MJ, Lester M, McNamara C, Milby JB, Schumacher JE: Cell phones for ecological momentary assessment with cocaine-addicted homeless patients in treatment. J Subst Abuse Treat 2006; 30:105-111 (Pubitemid 43259362)
16. Krahn DD, Bohn MJ, Henk HJ, Grossman JL, Gosnell B: Patterns of urges during early abstinence in alcohol-dependent subjects. Am J Addict 2005; 14:248-255 (Pubitemid 40981211)
17. Lukasiewicz M, Benyamina A, Reynaud M, Falissard B: An in vivo study of the relationship between craving and reaction time during alcohol detoxification using the ecological momentary assessment. Alcohol Clin Exp Res 2005; 29:2135-2143 (Pubitemid 43042804)
18. Swendsen J, Tennen H, Carney M, Affleck G, Willard A, Hromi A: Mood and alcohol consumption: an experience sampling test of the self-medication hypothesis. J Abnorm Psychol 2000; 109:198-204 (Pubitemid 30616916)
19. Granholm E, Loh C, Swendsen J: Feasibility and validity of computerized ecological momentary assessment in schizophrenia. Schizophr Bull 2008; 34:507-514
20. Kimhy D, Delespaul P, Ahn H, Cai S, Shikhman M, Lieberman JA, Malaspina D, Sloan RP: Concurrent measurement of "real world" stress and arousal in individuals with psychosis: assessing the feasibility and validity of a novel methodology. Schizophr Bull (Epub ahead of print, May 8, 2009)
21. Kimhy D, Delespaul P, Corcoran C, Ahn H, Yale S, Malaspina D: Computerized experience sampling method (ESMc): assessing feasibility and validity among individuals with schizophrenia. J Psychiatr Res 2006; 40:221-230 (Pubitemid 43214629)
22. Broderick JE, Schwartz JE, Shiffman S, Hufford MR, Stone AA: Signaling does not adequately improve diary compliance. Ann Behav Med 2003; 26:139-148 (Pubitemid 37271600)
23. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR: Patient compliance with paper and electronic diaries. Control Clin Trials 2003; 24:182-199 (Pubitemid 36412017)
24. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276 (Pubitemid 18039085)
25. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York, New York State Psychiatric Institute, Biometrics Research, 1995
26. Weiss HM, Beal DJ, Lucy SL, MacDermid SM: Constructing EMA studies with PMAT: the Purdue Momentary Assessment Tool user's manual. West Lafayette, Ind, Purdue University, Military Family Research Institute, 2004
27. Johnson EI, Grondin O, Barrault M, Faytout M, Helbig S, Husky M, Granholm EL, Loh C, Nadeau L, Wittchen HU, Swendsen J: Computerized ambulatory monitoring in psychiatry: a multi-site collaborative study of acceptability, compliance, and reactivity. Int J Methods Psychiatr Res 2009; 18:48-57
28. Haddock G, McCarron J, Tarrier N, Faragher EB: Scales to measure dimensions of hallucinations and delusions: the Psychotic Symptom Rating Scales (PSYRATS). Psychol Med 1999; 29:879-889 (Pubitemid 29381048)
29. Raudenbush S, Bryk A, Congdon R: HLM for Windows, Version 6.03. Lincolnwood, Ill, Scientific Software International, 2005
30. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR: What does the PANSS mean? Schizophr Res 2005; 79:231-238
31. Chakroun N, Johnson EI, Swendsen J: Mood and personality-based models of substance use. Psychol Addict Behav 2010; 24:129-136
32. Andreasson S, Allebeck P, Engstrom A, Rydberg U: Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; 2:1483-1486
33. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE: Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325:1212-1213 (Pubitemid 35398785)
34. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G: Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325:1183-1184
35. Ferdinand RF, Sondeijker F, van der Ende J, Selten JP, Huizink A, Verhulst FC: Cannabis use predicts future psychotic symptoms, and vice versa. Addiction 2005; 100:612-618 (Pubitemid 40646286)
36. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H: Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002; 156:319-327 (Pubitemid 34857999)
37. Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen J: Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med 2003; 33:23-32 (Pubitemid 36113397)
38. Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y: A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006; 63:426-432
39. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, Giampietro V, Mechelli A, Atakan Z, McGuire P: Modulation of mediotemporal and ventrostriatal function in humans by delta9-tetrahydrocannabinol: a neural basis for the effects of cannabis sativa on learning and psychosis. Arch Gen Psychiatry 2009; 66:442-451
40. Curran C, Byrappa N, McBride A: Stimulant psychosis: systematic review. Br J Psychiatry 2004; 185:196-204 (Pubitemid 39208220)